Announcements Trials
Browse Landscape

Phase

Phase 2 6Phase 3 2Phase 1/2 1Phase 1 1

Status

Recruiting 4Withdrawn 1Not yet recruiting 1

Sponsor Class

OTHER 4NETWORK 1INDUSTRY 1

Study Type

Interventional 6

Sponsor

Cancer Type

Thoracic 4Tumor-Agnostic 1Genitourinary 1

Conditions

Small Cell Lung Carcinoma 2Carcinoma, Non-Small-Cell Lung 2Non-Muscle Invasive Bladder Neoplasms 1Neoplasms 1Lung Neoplasms 1

Interventions

pembrolizumab 512Specimen Handling 381Carboplatin 371Magnetic Resonance Spectroscopy 333Cisplatin 327Nivolumab 302Cyclophosphamide 295Radiotherapy 254Paclitaxel 252Biopsy 235Gemcitabine 229Bevacizumab 212Dexamethasone 167durvalumab 162Oxaliplatin 160Capecitabine 154Rituximab 151Fluorouracil 148venetoclax 142atezolizumab 141Docetaxel 141Drug Therapy 140Etoposide 138Doxorubicin 131Ipilimumab 125Radiosurgery 118Lenalidomide 117Prednisone 116Leucovorin 111fludarabine 109

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Phase 2 × monalizumab × 1 year × Clear all
NCT05061550 2026-05-22

NeoCOAST-2

AstraZeneca

Phase 2 Recruiting
630 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT07146230 2026-05-06

SPRINT 2

Montefiore Medical Center

Phase 2 Not yet recruiting
52 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT05903092 2026-04-29

MOZART

Hoosier Cancer Research Network

Phase 2 Recruiting
84 enrolled
Thoracic

Small Cell Lung Carcinoma

NCT06503614 2026-04-08

ENHANCE

Hoosier Cancer Research Network

Phase 2 Recruiting
60 enrolled
Genitourinary

Non-Muscle Invasive Bladder Neoplasms

NCT06152523 2026-04-06

MONAMI

Assistance Publique - Hôpitaux de Paris

Phase 2 Withdrawn
Tumor-Agnostic

Neoplasms

NCT06769126 2026-03-30

Using Biomarker Tests to Select and Test New, Personalized Treatments for Extensive Stage Small Cell Lung Cancer, PRISM Study

SWOG Cancer Research Network

Phase 2 Recruiting
900 enrolled
Thoracic

Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡